Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-07 Purchase |
2025-02-11 7:00 pm |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
97,561 | $2.05 | $200,000 | 151,231 (Direct) |
View |
| 2025-02-07 Purchase |
2025-02-11 5:00 pm |
Oncocyte Corp | OCX | SMITH PATRICK W 10% Owner |
1,077,600 | $2.05 | $2,209,080 | 3,644,299 (Indirect) |
View |
| 2025-02-06 Purchase |
2025-02-10 8:43 pm |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
5,165,695 | $2.05 | $10,589,675 | 23,120,543 (Indirect Direct) |
View |
| 2025-01-31 Purchase |
2025-02-04 4:45 pm |
Oncocyte Corp | OCX | SMITH PATRICK W 10% Owner |
915 | $2.0103 | $1,839 | 1,795,071 (Indirect) |
View |
| 2025-01-29 Purchase |
2025-01-31 5:00 pm |
Oncocyte Corp | OCX | SMITH PATRICK W 10% Owner |
4,198 | $2.01 | $8,438 | 1,794,156 (Indirect) |
View |
| 2025-01-13 Purchase |
2025-01-15 5:00 pm |
Oncocyte Corp | OCX | SMITH PATRICK W 10% Owner |
16,055 | $2.1248 | $34,114 | 1,789,958 (Indirect) |
View |
| 2024-12-26 Purchase |
2024-12-27 9:49 pm |
Oncocyte Corp | OCX | SMITH PATRICK W 10% Owner |
90,219 | $2.13 | $192,166 | 1,773,903 (Indirect) |
View |
| 2024-12-26 Purchase |
2024-12-26 6:17 pm |
Oncocyte Corp | OCX | Arno Andrew Director |
12,500 | $2.108 | $26,350 | 97,162 (Indirect Direct) |
View |
| 2024-12-05 Purchase |
2024-12-09 08:00 am |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
20,000 | $2.29 | $45,800 | 53,670 (Direct) |
View |
| 2024-10-02 Purchase |
2024-10-04 7:40 pm |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
33,670 | $2.97 | $100,000 | 33,670 (Direct) |
View |
| 2024-10-02 Purchase |
2024-10-04 7:00 pm |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
1,315,339 | $2.948 | $3,877,619 | 12,789,153 (Indirect Direct) |
View |
| 2024-04-11 Purchase |
2024-04-15 7:21 pm |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
2,420,000 | $2.9164 | $7,057,688 | 10,158,475 (Indirect Direct) |
View |
| 2024-04-11 Purchase |
2024-04-15 06:04 am |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
3,390 | $2.95 | $10,001 | 3,505 (Direct) |
View |
| 2024-04-11 Purchase |
2024-04-15 06:02 am |
Oncocyte Corp | OCX | Arno Andrew Director |
33,898 | $2.95 | $99,999 | 84,662 (Indirect Direct) |
View |
| 2023-06-14 Purchase |
2023-06-15 8:13 pm |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
30,000 | $0.2149 | $6,447 | 563,223 (Indirect Direct) |
View |
| 2023-04-05 Purchase |
2023-04-07 5:12 pm |
Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner |
663,000 | $0.3017 | $200,027 | 14,829,163 (Indirect) |
View |
| 2023-04-03 Purchase |
2023-04-05 9:35 pm |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
26,827,638 | $0.3017 | $8,093,898 | 112,385,084 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-26 Option Award |
2025-03-28 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
113,207 | $0 | 113,207 (Direct) |
View |
| 2025-03-26 Option Award |
2025-03-28 4:05 pm |
N/A 2035-03-26 |
Oncocyte Corp | OCX | Liu James Yang VP ACCT, Cntlr, Treasurer, PAO |
28,867 | $0 | 28,867 (Direct) |
View |
| 2025-03-26 Option Award |
2025-03-28 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
188,679 | $0 | 188,679 (Direct) |
View |
| 2025-02-07 Other |
2025-02-11 5:00 pm |
N/A N/A |
Oncocyte Corp | OCX | SMITH PATRICK W 10% Owner |
385,814 | $2.05 | 3,644,299 (Indirect) |
View |
Ownership |
2024-12-27 9:42 pm |
N/A N/A |
Oncocyte Corp | OCX | SMITH PATRICK W 10% Owner |
0 | $0 | 1,683,684 (Indirect) |
View |
| 2024-10-11 Option Award |
2024-10-15 4:15 pm |
N/A 2034-06-20 |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 9:00 pm |
N/A 2034-07-01 |
Oncocyte Corp | OCX | Arno Andrew Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 9:00 pm |
N/A 2034-07-01 |
Oncocyte Corp | OCX | Last Andrew J. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 9:00 pm |
N/A 2034-07-01 |
Oncocyte Corp | OCX | SILVERMAN LOU Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 4:49 pm |
N/A N/A |
Oncocyte Corp | OCX | James Andrea S. Chief Financial Officer |
300,000 | $0 | 500,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-22 5:18 pm |
N/A 2034-05-20 |
Oncocyte Corp | OCX | Liu James Yang Sr Dir., Cntlr, PAO, Int PFO |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-22 4:58 pm |
N/A 2034-05-20 |
Oncocyte Corp | OCX | Arno Andrew Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-22 4:56 pm |
N/A 2034-05-20 |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
90,000 | $0 | 90,000 (Direct) |
View |
| 2024-04-15 Other |
2024-04-15 7:21 pm |
N/A N/A |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
2,941 | $0 | 10,158,475 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-12 4:30 pm |
N/A 2033-10-10 |
Oncocyte Corp | OCX | Liu James Yang Sr Dir Controller PAO Int PFO |
8,482 | $0 | 8,482 (Direct) |
View |
| 2023-08-15 Option Award |
2023-08-17 6:57 pm |
N/A 2033-08-15 |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-30 Other |
2023-07-03 6:00 pm |
N/A 2027-04-19 |
Oncocyte Corp | OCX | Gutfreund John Peter Former Director Director |
6,649,775 | $0 | 7,941,914 (Indirect) |
View |
| 2023-06-23 Option Award |
2023-06-27 9:30 pm |
N/A 2033-06-23 |
Oncocyte Corp | OCX | Arno Andrew Director |
165,000 | $0 | 1,150,301 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 9:30 pm |
N/A 2033-06-23 |
Oncocyte Corp | OCX | Last Andrew J. Director |
110,000 | $0 | 180,170 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 9:30 pm |
N/A 2033-06-23 |
Oncocyte Corp | OCX | KINGSLEY ALFRED D Director |
110,000 | $0 | 673,223 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 9:30 pm |
N/A 2033-06-23 |
Oncocyte Corp | OCX | SILVERMAN LOU Director |
137,500 | $0 | 143,770 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 4:05 pm |
N/A 2033-06-09 |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
1,150,000 | $0 | 1,150,000 (Direct) |
View |
| 2023-03-06 Other(A) |
2023-04-18 6:49 pm |
2022-04-19 2027-04-19 |
Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner |
4,331,075 | $0 | 20,481,163 (Indirect) |
View |